{
    "study_accession": "SDY64",
    "actual_completion_date": null,
    "actual_enrollment": 36,
    "actual_start_date": null,
    "age_unit": "Weeks",
    "brief_description": "A comparison between large and small droplet flu vaccination",
    "brief_title": "Aerosol vaccination in mice",
    "clinical_trial": "N",
    "condition_studied": null,
    "dcl_id": 2,
    "description": "Evaluation of the parameters required for effective aerosol delivery of influenza virus in mice using controlled 20 and 30 m MMAD particle aerosols as proof of concept for LAIV aerosol delivery",
    "doi": "10.21430/M3DU77M662",
    "endpoints": "HAI, levels of IgA and IgG antibodies of lung homogenates",
    "gender_included": "Not Specified",
    "hypothesis": "Demonstrating the feasibility of nasal vaccination using aerosolized particles",
    "initial_data_release_date": "2013-06-12",
    "initial_data_release_version": "DR2",
    "intervention_agent": "A/Hong Kong/1/68 x A/Puerto Rico/8/34 (X31;N3N2)",
    "latest_data_release_date": "2013-06-12",
    "latest_data_release_version": "DR2",
    "maximum_age": "   6.00",
    "minimum_age": "   6.00",
    "objectives": "Demonstrating the feasibility of nasal vaccination using aerosolized particles",
    "official_title": "Aerosol vaccination induces robust protective immunity to homologous and heterologous influenza infection in mice",
    "sponsoring_organization": "NIAID",
    "target_enrollment": null,
    "workspace_id": 2149,
    "research_focus": [
        "Vaccine Response"
    ],
    "arm": [
        {
            "arm_accession": "ARM496",
            "description": "mice were inoculated with 100 ul of live X31 influenza virus with 10*2(TCID50/ml) titer by intranasal delivery",
            "name": "live X31 - intranasal"
        },
        {
            "arm_accession": "ARM497",
            "description": "mice were inoculated with live X31 influenza virus with 10*2(TCID50/ml) titer by mask aerosol delivery (20 micron droplets) for 15 sec and a flow rate of 1 cm*3/min",
            "name": "live X31 -aerosol -20 M- 15 sec"
        },
        {
            "arm_accession": "ARM498",
            "description": "mice were inoculated with live X31 influenza virus with 10*2(TCID50/ml) titer by mask aerosol delivery (20 micron droplets) for 30 sec and a flow rate of 1 cm*3/min",
            "name": "live X31 -aerosol -20 M- 30 sec"
        },
        {
            "arm_accession": "ARM499",
            "description": "mice were inoculated with live X31 influenza virus with 10*2(TCID50/ml) titer by mask aerosol delivery (20 micron droplets) for 45 sec and a flow rate of 1 cm*3/min",
            "name": "live X31 -aerosol -20 M- 45 sec"
        },
        {
            "arm_accession": "ARM500",
            "description": "mice were inoculated with live X31 influenza virus with 10*2(TCID50/ml) titer by mask aerosol delivery (30 micron droplets) for 15 sec and a flow rate of 1 cm*3/min.",
            "name": "live X31 -aerosol -30 M- 15 sec"
        },
        {
            "arm_accession": "ARM501",
            "description": "mice were inoculated with live X31 influenza virus with 10*2(TCID50/ml) titer by mask aerosol delivery (30 micron droplets) for 30 sec and a flow rate of 1 cm*3/min",
            "name": "live X31 -aerosol -30 M- 30 sec"
        },
        {
            "arm_accession": "ARM502",
            "description": "mice were inoculated with live X31 influenza virus with 10*2(TCID50/ml) titer by mask aerosol delivery (30 micron droplets) for 15 sec and a flow rate of 1 cm*3/min.",
            "name": "live X31 -aerosol -30 M- 45 sec"
        },
        {
            "arm_accession": "ARM503",
            "description": "mice were inoculated with 100 ul of live X31 influenza virus with 10*1(TCID50/ml) titer by intranasal delivery",
            "name": "live X31 -intranasal-10*1(TCID50/ml)"
        },
        {
            "arm_accession": "ARM504",
            "description": "mice were inoculated with 100 ul of live X31 influenza virus with 10*2(TCID50/ml) titer by intranasal delivery",
            "name": "live X31 -intranasal-10*2(TCID50/ml)"
        },
        {
            "arm_accession": "ARM505",
            "description": "mice were inoculated with 100 ul of live X31 influenza virus with 10*3(TCID50/ml) titer by intranasal delivery",
            "name": "live X31 -intranasal-10*3(TCID50/ml)"
        },
        {
            "arm_accession": "ARM506",
            "description": "mice were inoculated with 100 ul of live X31 influenza virus with 10*4(TCID50/ml) titer by intranasal delivery",
            "name": "live X31 -intranasal-10*4(TCID50/ml)"
        },
        {
            "arm_accession": "ARM507",
            "description": "mice were inoculated with 100 ul of live X31 influenza virus with 10*5(TCID50/ml) titer by intranasal delivery",
            "name": "live X31 -intranasal-10*5(TCID50/ml)"
        },
        {
            "arm_accession": "ARM508",
            "description": "mice were inoculated with live X31 influenza virus with 10*1(TCID50/ml) titer by mask aerosol delivery (30 micron droplets) for 15 sec and a flow rate of 1 cm*3/min.",
            "name": "live X31 -aerosol -30 M-10*1(TCID50/ml)"
        },
        {
            "arm_accession": "ARM509",
            "description": "mice were inoculated with live X31 influenza virus with 10*2(TCID50/ml) titer by mask aerosol delivery (30 micron droplets) for 15 sec and a flow rate of 1 cm*3/min.",
            "name": "live X31 -aerosol -30 M-10*2(TCID50/ml)"
        },
        {
            "arm_accession": "ARM510",
            "description": "mice were inoculated with live X31 influenza virus with 10*3(TCID50/ml) titer by mask aerosol delivery (30 micron droplets) for 15 sec and a flow rate of 1 cm*3/min.",
            "name": "live X31 -aerosol -30 M-10*3(TCID50/ml)"
        },
        {
            "arm_accession": "ARM511",
            "description": "mice were inoculated with live X31 influenza virus with 10*4(TCID50/ml) titer by mask aerosol delivery (30 micron droplets) for 15 sec and a flow rate of 1 cm*3/min.",
            "name": "live X31 -aerosol -30 M-10*4(TCID50/ml)"
        },
        {
            "arm_accession": "ARM512",
            "description": "mice were inoculated with live X31 influenza virus with 10*5(TCID50/ml) titer by mask aerosol delivery (30 micron droplets) for 15 sec and a flow rate of 1 cm*3/min.",
            "name": "live X31 -aerosol -30 M-10*5(TCID50/ml)"
        },
        {
            "arm_accession": "ARM513",
            "description": "mice were inoculated with live X31 influenza virus with 10*3(TCID50/ml) titer by mask aerosol delivery (30 micron droplets) for 15 sec and a flow rate of 0.1 cm*3/min.",
            "name": "live X31 -aerosol -30 M-10*3(TCID50/ml)-0.1 cc/min"
        },
        {
            "arm_accession": "ARM514",
            "description": "mice were inoculated with live X31 influenza virus with 10*3(TCID50/ml) titer by mask aerosol delivery (30 micron droplets) for 15 sec and a flow rate of 0.5 cm*3/min.",
            "name": "live X31 -aerosol -30 M-10*3(TCID50/ml)-0.5 cc/min"
        },
        {
            "arm_accession": "ARM515",
            "description": "mice were inoculated with live X31 influenza virus with 10*3(TCID50/ml) titer by mask aerosol delivery (30 micron droplets) for 15 sec and a flow rate of 1 cm*3/min.",
            "name": "live X31 -aerosol -30 M-10*3(TCID50/ml)-1 cc/min"
        },
        {
            "arm_accession": "ARM516",
            "description": "mice were inoculated with live X31 influenza virus with 10*3(TCID50/ml) titer by mask aerosol delivery (30 micron droplets) for 15 sec and a flow rate of 2 cm*3/min.",
            "name": "live X31 -aerosol -30 M-10*3(TCID50/ml)-2 cc/min"
        },
        {
            "arm_accession": "ARM517",
            "description": "mice were inoculated with live X31 influenza virus with 10*2(TCID50/ml) titer by mask aerosol delivery (30 micron droplets)",
            "name": "live X31 -aerosol -30 M-10*2(TCID50/ml)"
        },
        {
            "arm_accession": "ARM518",
            "description": "mice were inoculated with live X31 influenza virus with 10*3(TCID50/ml) titer by mask aerosol delivery (30 micron droplets)",
            "name": "live X31 -aerosol -30 M-10*3(TCID50/ml)"
        },
        {
            "arm_accession": "ARM519",
            "description": "mice were inoculated with live X31 influenza virus with 10*4(TCID50/ml) titer by mask aerosol delivery (30 micron droplets)",
            "name": "live X31 -aerosol -30 M-10*4(TCID50/ml)"
        },
        {
            "arm_accession": "ARM520",
            "description": "mice were inoculated with live X31 influenza virus with 10*5(TCID50/ml) titer by mask aerosol delivery (30 micron droplets)",
            "name": "live X31 -aerosol -30 M-10*5(TCID50/ml)"
        },
        {
            "arm_accession": "ARM521",
            "description": "mice were inoculated with live X31 influenza virus with 10*6(TCID50/ml) titer by mask aerosol delivery (30 micron droplets)",
            "name": "live X31 -aerosol -30 M-10*6(TCID50/ml)"
        },
        {
            "arm_accession": "ARM522",
            "description": "Mice primary immunized with X31 intramuscular. then 14 days later infected with lethal dose X31",
            "name": "Vaccinated:  X31 i.m. inoculation , 14 dpi: live virus X31"
        },
        {
            "arm_accession": "ARM523",
            "description": "Mice primary immunized with  X31 intramuscular. then 14 days later infected with lethal dose PR8",
            "name": "Vaccinated:  X31 i.m. inoculation , 14 dpi: live virus PR8"
        },
        {
            "arm_accession": "ARM524",
            "description": "Mice primary immunized with X31 intranasal. then 14 days later infected with lethal dose X31",
            "name": "Vaccinated:  X31 i.n. inoculation , 14 dpi: live virus X31"
        },
        {
            "arm_accession": "ARM525",
            "description": "Mice primary immunized with X31 intranasal. then 14 days later infected with lethal dose PR8",
            "name": "Vaccinated:  X31 i.n. inoculation , 14 dpi: live virus PR8"
        },
        {
            "arm_accession": "ARM526",
            "description": "Mice primary immunized with X31 aerosol. then 14 days later infected with lethal dose X31",
            "name": "Vaccinated: X31 aerosol  inoculation , 14 dpi: live virus X31"
        },
        {
            "arm_accession": "ARM527",
            "description": "Mice primary immunized with X31 aerosol. then 14 days later infected with lethal dose PR8",
            "name": "Vaccinated:  X31 aerosol  inoculation , 14 dpi: live virus PR8"
        },
        {
            "arm_accession": "ARM528",
            "description": "Naive group challenged with lethal dose of X31",
            "name": "Naive, challenged live virus X31"
        },
        {
            "arm_accession": "ARM529",
            "description": "Naive group challenged with lethal dose of PR8",
            "name": "Naive, challenged live virus PR8"
        },
        {
            "arm_accession": "ARM530",
            "description": "Vaccinated: X31 i.m.",
            "name": "Vaccinated: X31 i.m."
        },
        {
            "arm_accession": "ARM531",
            "description": "Vaccinated:  X31 i.n.",
            "name": "Vaccinated:  X31 i.n."
        },
        {
            "arm_accession": "ARM532",
            "description": "Vaccinated:  X31 aerosal",
            "name": "Vaccinated:  X31 aerosal"
        },
        {
            "arm_accession": "ARM533",
            "description": "Naive",
            "name": "Naive"
        }
    ],
    "personnel": [
        {
            "first_name": "Ralph",
            "last_name": "Tripp",
            "organization": "College of Veterinary Medicine, University of Georgia",
            "role_in_study": "Principal Investigator",
            "site_name": "\r"
        }
    ],
    "pubmed": [
        {
            "title": "Aerosol vaccination induces robust protective immunity to homologous and heterologous influenza infection in mice.",
            "journal": "Vaccine.",
            "month": "Mar",
            "year": "2011",
            "doi": "10.1016/j.vaccine.2011.01.059. Epub 2011 Feb 5.",
            "pubmed_id": "21300100"
        }
    ],
    "program": [
        {
            "program_name": "NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS)",
            "contract_name": "Influenza Pathogenesis & Immunology Research Center (IPIRC)"
        }
    ],
    "assay": [
        {
            "measurement_technique": "ELISA",
            "number_of_expsamples": 168
        },
        {
            "measurement_technique": "Hemagglutination Inhibition",
            "number_of_expsamples": 14
        },
        {
            "measurement_technique": "TCID50",
            "number_of_expsamples": 62
        }
    ],
    "subject": {
        "race": [],
        "gender": []
    }
}
